Scholarlink

Background <p>Polycystic ovarian syndrome (PCOS) is an inflammatory autophagy-deficient disorder&#xa0;with downregulated Nrf2. Scoparone (SCPN), a natural compound from Chinese medicine, directly activates Nrf2 and clinically showed promises in treating inflammatory disorders. Studies reported SCPN’s ability to induce autophagy; yet no study tested SCPN’s ability in correcting disturbed autophagy in PCOS. The present research aim was to examine SCPN’s influence&#xa0;on PCOS-associated autophagic disturbances.</p> Methods <p>PCO was induced by Letrozole (1&#xa0;mg/kg, p.o.) for 21&#xa0;days and SCPN (12.5&#xa0;mg/kg, i.p.) either alone or in parallel with an autophagy inhibitor, 3-methyl adenine, for 7&#xa0;days.</p> Results <p>Hematoxylin and eosin (H&amp;E) staining revealed reduced ovarian cysts with mature follicles recovery with SCPN. The immunolabeled ovarian tissues demonstrated that SCPN increased nuclear factor erythroid 2-related factor 2 (Nrf2) expression together with autophagic markers Beclin1, microtubule-associated protein light chain 3 (LC3), and autophagy enzyme 7 while decreasing P62. This signaling activation may be interpreted by autophagic signals upregulation; Sirtuin 1/liver kinase B1/AMP-activated protein kinase (Sirt1/LKB1/AMPK). A downregulation of inflammatory mediators, viz. tumor necrosis factor-alpha (TNF-α) and p65-nuclear factor kappa B (NF-κB) in PCOS ovaries, is associated by restoration of estradiol and FSH/LH balance. Concomitantly, SCPN abrogated testosterone and anti-Müllerian hormone levels besides insulin resistance and leptin levels.</p> Conclusions <p>The current study showed mutual link between Nrf2 and autophagic pathway. SCPN showed anti-inflammatory character with autophagic improvement in PCOS may be through Nrf2 activation.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The potential effect of scoparone in autophagic disruption associated with PCOS in Letrozole rat model: role of Nrf2 and Sirt1/LKB1/AMPK signaling

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月14日

查看全文
  • Ahmed S. Kamel,
  • Nesrine S. El Sayed,
  • Barbara Budzyńska,
  • Krystyna Skalicka-Woźniak,
  • Sarah S. El-Sayed

摘要

Background

Polycystic ovarian syndrome (PCOS) is an inflammatory autophagy-deficient disorder with downregulated Nrf2. Scoparone (SCPN), a natural compound from Chinese medicine, directly activates Nrf2 and clinically showed promises in treating inflammatory disorders. Studies reported SCPN’s ability to induce autophagy; yet no study tested SCPN’s ability in correcting disturbed autophagy in PCOS. The present research aim was to examine SCPN’s influence on PCOS-associated autophagic disturbances.

Methods

PCO was induced by Letrozole (1 mg/kg, p.o.) for 21 days and SCPN (12.5 mg/kg, i.p.) either alone or in parallel with an autophagy inhibitor, 3-methyl adenine, for 7 days.

Results

Hematoxylin and eosin (H&E) staining revealed reduced ovarian cysts with mature follicles recovery with SCPN. The immunolabeled ovarian tissues demonstrated that SCPN increased nuclear factor erythroid 2-related factor 2 (Nrf2) expression together with autophagic markers Beclin1, microtubule-associated protein light chain 3 (LC3), and autophagy enzyme 7 while decreasing P62. This signaling activation may be interpreted by autophagic signals upregulation; Sirtuin 1/liver kinase B1/AMP-activated protein kinase (Sirt1/LKB1/AMPK). A downregulation of inflammatory mediators, viz. tumor necrosis factor-alpha (TNF-α) and p65-nuclear factor kappa B (NF-κB) in PCOS ovaries, is associated by restoration of estradiol and FSH/LH balance. Concomitantly, SCPN abrogated testosterone and anti-Müllerian hormone levels besides insulin resistance and leptin levels.

Conclusions

The current study showed mutual link between Nrf2 and autophagic pathway. SCPN showed anti-inflammatory character with autophagic improvement in PCOS may be through Nrf2 activation.